Publicação
Tumor-Infiltrating T Cells in Skin Basal Cell Carcinomas and Squamous Cell Carcinomas: Global Th1 Preponderance with Th17 Enrichment—A Cross-Sectional Study
| dc.contributor.author | Cunha, D | |
| dc.contributor.author | Neves, M | |
| dc.contributor.author | Silva, D | |
| dc.contributor.author | Silvestre, AR | |
| dc.contributor.author | Nunes, PB | |
| dc.contributor.author | Arrobas, F | |
| dc.contributor.author | Ribot, JC | |
| dc.contributor.author | Ferreira, F | |
| dc.contributor.author | Moita, LF | |
| dc.contributor.author | Soares-de-Almeida, L | |
| dc.contributor.author | Silva, JM | |
| dc.contributor.author | Filipe, P | |
| dc.contributor.author | Ferreira, J | |
| dc.date.accessioned | 2024-06-30T21:43:42Z | |
| dc.date.available | 2024-06-30T21:43:42Z | |
| dc.date.issued | 2024 | |
| dc.description.abstract | Basal cell carcinomas (BCCs) and squamous cell carcinomas (SCCs) are high-incidence, non-melanoma skin cancers (NMSCs). The success of immune-targeted therapies in advanced NMSCs led us to anticipate that NMSCs harbored significant populations of tumor-infiltrating lymphocytes with potential anti-tumor activity. The main aim of this study was to characterize T cells infiltrating NMSCs. Flow cytometry and immunohistochemistry were used to assess, respectively, the proportions and densities of T cell subpopulations in BCCs (n = 118), SCCs (n = 33), and normal skin (NS, n = 30). CD8+ T cells, CD4+ T cell subsets, namely, Th1, Th2, Th17, Th9, and regulatory T cells (Tregs), CD8+ and CD4+ memory T cells, and γδ T cells were compared between NMSCs and NS samples. Remarkably, both BCCs and SCCs featured a significantly higher Th1/Th2 ratio (~four-fold) and an enrichment for Th17 cells. NMSCs also showed a significant enrichment for IFN-γ-producing CD8+T cells, and a depletion of γδ T cells. Using immunohistochemistry, NMSCs featured denser T cell infiltrates (CD4+, CD8+, and Tregs) than NS. Overall, these data favor a Th1-predominant response in BCCs and SCCs, providing support for immune-based treatments in NMSCs. Th17-mediated inflammation may play a role in the progression of NMSCs and thus become a potential therapeutic target in NMSCs. | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | Cells . 2024 Jun 3;13(11):964. | pt_PT |
| dc.identifier.doi | 10.3390/cells13110964 | pt_PT |
| dc.identifier.uri | http://hdl.handle.net/10400.26/51180 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.subject | Carcinoma Basocelular | pt_PT |
| dc.subject | Carcinoma de Células Escamosas | pt_PT |
| dc.subject | Linfócitos do Interstício Tumoral | pt_PT |
| dc.subject | Neoplasias da Pele | pt_PT |
| dc.subject | Células Th1 | pt_PT |
| dc.subject | Carcinoma, Basal Cell | pt_PT |
| dc.subject | Carcinoma, Squamous Cell | pt_PT |
| dc.subject | Lymphocytes, Tumor-Infiltrating | pt_PT |
| dc.subject | Skin Neoplasms | pt_PT |
| dc.subject | Th1 Cells | pt_PT |
| dc.title | Tumor-Infiltrating T Cells in Skin Basal Cell Carcinomas and Squamous Cell Carcinomas: Global Th1 Preponderance with Th17 Enrichment—A Cross-Sectional Study | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.issue | 11 | pt_PT |
| oaire.citation.startPage | 964 | pt_PT |
| oaire.citation.title | Cells | pt_PT |
| oaire.citation.volume | 13 | pt_PT |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | article | pt_PT |
